{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:34:19Z","timestamp":1780652059115,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.canrad.2025.104629","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T16:00:53Z","timestamp":1747756853000},"page":"104629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database"],"prefix":"10.1016","volume":"29","author":[{"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canrad.2025.104629_bib0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/107327480401100502","article-title":"Intraocular lymphoma:update on diagnosis and management","volume":"11","author":"Chan","year":"2004","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.canrad.2025.104629_bib0120","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.survophthal.2021.03.004","article-title":"Primary central nervous system lymphoma\u2013ocular variant: an interdisciplinary review on management","volume":"66","author":"Raval","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104629_bib0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2217\/fon.12.40","article-title":"Subcutaneous diffuse large B-cell lymphoma with intraocular involvement","volume":"8","author":"Chi","year":"2012","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104629_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2013.09.004","article-title":"Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes","volume":"121","author":"Aronow","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.canrad.2025.104629_bib0135","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2013.74","article-title":"Choroidal and adnexal extranodal marginal zone B-cell lymphoma: presentation, imaging findings, and therapeutic management in a series of nine cases","volume":"27","author":"Loriaut","year":"2013","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.canrad.2025.104629_bib0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0002-9394(03)00324-6","article-title":"A case of primary B-cell type non-Hodgkin lymphoma originating in the iris","volume":"136","author":"Yamada","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"17","key":"10.1016\/j.canrad.2025.104629_bib0145","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/cancers14174274","article-title":"Prospective study of 4Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL)","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.canrad.2025.104629_bib0150","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","article-title":"Response-adapted ultra-low-dose 4Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial","volume":"11","author":"Gunther","year":"2024","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104629_bib0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologis"},{"issue":"2","key":"10.1016\/j.canrad.2025.104629_bib0160","doi-asserted-by":"crossref","first-page":"NP91","DOI":"10.1177\/1120672119888985","article-title":"Ultra-low-dose (boom-boom) radiotherapy for choroidal lymphoma in three consecutive cases","volume":"31","author":"Yang","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104629_bib0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-022-00288-0","article-title":"Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report","volume":"12","author":"Flanagan","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"10.1016\/j.canrad.2025.104629_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104629_bib0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4Gy versus 24Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.canrad.2025.104629_bib0180","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","article-title":"Excellent response to very-low-dose radiation (4Gy) for indolent B-cell lymphomas: is 4Gy suitable for curable patients?","volume":"5","author":"Imber","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.canrad.2025.104629_bib0185","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.12.004","article-title":"Lens dose-response prediction modeling and cataract incidence in patients with retinoblastoma after lens-sparing or whole-eye radiation therapy","volume":"103","author":"Nguyen","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104629_bib0190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canrad.2021.11.001","article-title":"Organs at risk radiation dose constraints","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104629_bib0195","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2147\/OPTH.S263291","article-title":"Ocular complications after radiation therapy: an observational study","volume":"14","author":"Nuzzi","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.canrad.2025.104629_bib0200","series-title":"Annual update in intensive care and emergency medicine 2018","first-page":"579","article-title":"Rituximab-related severe toxicity","author":"Ghrenassia","year":"2018"},{"issue":"3","key":"10.1016\/j.canrad.2025.104629_bib0205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.radonc.2013.12.002","article-title":"Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer","volume":"110","author":"Abo-Madyan","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104629_bib0210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3928\/15428877-20060501-10","article-title":"Indocyanine green angiographic features of systemic non-Hodgkin's lymphoma and bilateral choroidal involvement","volume":"37","author":"Saatci","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3","key":"10.1016\/j.canrad.2025.104629_bib0215","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ophtha.2002.10.002","article-title":"Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin","volume":"111","author":"Johnston","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.canrad.2025.104629_bib0220","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ophtha.2006.02.048","article-title":"Transretinal choroidal tumor biopsy with a 25-gauge vitrector","volume":"113","author":"Sen","year":"2006","journal-title":"Ophthalmology"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:07:16Z","timestamp":1749229636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1278321825000459"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104629","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104629"}}